Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease
- 1 January 2003
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (2), 121-127
- https://doi.org/10.1016/s0002-9149(02)03095-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groupsAnnals of Epidemiology, 1997
- Smoking Cessation and Changes in Respiratory Symptoms in Two Populations Followed for 13 YearsInternational Journal of Epidemiology, 1993
- Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)The American Journal of Cardiology, 1993
- Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: The Framingham StudyAmerican Heart Journal, 1993
- Patterns of Absolute Risk of Lung Cancer Mortality in Former SmokersJNCI Journal of the National Cancer Institute, 1993
- Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.BMJ, 1989
- Cigarette Smoking and Risk of Stroke in Middle-Aged WomenNew England Journal of Medicine, 1988
- Risk of Stroke in Male Cigarette SmokersNew England Journal of Medicine, 1986
- Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years. Experience of an international collaborative groupPublished by American Medical Association (AMA) ,1982